Rakesh Jhunjhunwala’s Trust backed Stock reports profit growth of 268.89 per cent; Stock Surged 16.20 per cent in two days
Rakesh Jhunjhunwala’s Trust backed Stock reports profit growth of 268.89 per cent; Stock Surged 16.20 per cent in two days

Rakesh Jhunjhunwala’s Trust backed Stock reports profit growth of 268.89 per cent; Stock Surged 16.20 per cent in two days

The company is almost debt-free and has a high interest of Rakesh Jhunjhunwala's Trusts with an approximate 24 per cent stake

Prajwal Wakhare Article rating: 4.1

The company reported a record-breaking quarterly revenue of Rs 270.47 crore, marking an impressive 64 per cent year-over-year growth. The company's profits also soared, with a Profit After Tax (PAT) of Rs 81.01 crore, showing an astounding 268.89 per cent YoY increase and a PAT margin of 30.88 per cent, up 1331 basis points from the previous year.

IPO Analysis: Concord Biotech Limited
IPO Analysis: Concord Biotech Limited

IPO Analysis: Concord Biotech Limited

IPO Rating: Apply for long term

Prajwal Patil Article rating: 3.6

The price band of the issue has been fixed at Rs 705 to Rs 741 per equity share. The issue size is Rs 1,551 crore at a higher price band.

RSS

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR